Safety, Tolerability and Immunogenicity of ACI-24 Vaccine in Adults With Down Syndrome

NCT02738450 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Down Syndrome

Interventions

BIOLOGICAL: ACI-24 low dose
BIOLOGICAL: ACI-24 high dose
BIOLOGICAL: Placebo

Sponsor

AC Immune SA

Collaborators

[object Object]
[object Object]
[object Object]